Reparixin
- Generic Name
- Reparixin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H21NO3S
- CAS Number
- 266359-83-5
- Unique Ingredient Identifier
- U604E1NB3K
- Background
Reparixin has been used in trials studying the treatment and prevention of Breast Cancer, Metastatic Breast Cancer, Pancreatectomy for Chronic Pancreatitis, Islet Transplantation in Diabetes Mellitus Type 1, and Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus.
- Associated Conditions
- -
- Associated Therapies
- -
Reparixin in Pancreatic Islet Transplantation
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-10-14
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- Dompé Farmaceutici S.p.A
- Target Recruit Count
- 9
- Registration Number
- NCT01220856
- Locations
- 🇮🇹
Ospedale San Raffaele, Milan, Italy
🇩🇪University Hospital Carl Gustav Carus Dresden, Dresden, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath